News

Scientists at the Francis Crick Institute have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy.

A collaboration of scientists provide new evidence that a specific immune cell enzyme is increased in stressed mice, and in patients with major depressive disorder.

With all of the fantastic imaging techniques available in healthcare today, clinicians are capable of diagnosing tissue and joint deformities using non-invasive imaging with remarkable accuracy.

Study suggests that a pain relief drug can quickly and reversibly induce a sleep-like state in cells and organs could facilitate organ transplantation and prevent irreversible tissue injury.

An initial trial suggests a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome resulting from Covid-19.

Generative AI like ChatGPT can do more than help write emails — it can also design new drugs to treat disease, reports a new study that shows how AI can generate unique molecular structures as potential drugs.

Researchers have shown that targeting a protein called TACC3 (transforming acidic coiled-coil containing protein 3) can restore the effectiveness of the breast cancer drug T-DM1 if the cancer cells have developed resistance.

A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences.

A natural mechanism used by bacteria to protect themselves from viral attacks – by self-destructing – could be used to fight bacterial infections and antibiotic resistance.

Researchers discovered that a large proportion of lupus patients have antibodies to a protein called “Sm”, which is tightly linked to worse disease outcomes.